Question 1

What is LURBINECTEDIN used for?

Accepted Answer

LURBINECTEDIN (brand name ZEPZELCA) is a Other indicated for 1 INDICATIONS AND USAGE ZEPZELCA is an alkylating drug indicated: • in combination with atezolizumab or atezolizumab and hyaluronidase-tqjs, in combination with atezolizumab or atezolizumab and hyaluronidase-tqjs.

Question 2

How does LURBINECTEDIN work?

Accepted Answer

LURBINECTEDIN works through the following mechanism: 12.1 Mechanism of Action Lurbinectedin is an alkylating drug that binds guanine residues in the minor groove of DNA, forming adducts and resulting in a bending of the DNA helix towards the major groove. Adduct formation triggers a cascade of events that can affect the subsequent activity of DNA binding proteins, including some transcription factors, and DNA repair pathways, resulting in perturbation of the cell cycle and eventual cell death. Lurbinectedin inhibited human monocyte activity in vitro and reduced macrophage infiltration in implanted tumors in mice..

Question 3

What are the most common side effects of LURBINECTEDIN?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for LURBINECTEDIN. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is LURBINECTEDIN the same as ZEPZELCA?

Accepted Answer

ZEPZELCA is a brand name for LURBINECTEDIN. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

LURBINECTEDIN

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations